Key Takeaways
- Bioceres Crop Solutions reported total revenues of $39.4 million in Q3 FY2026, a 23% year-over-year decline, driven by softer demand and competitive pressure in Crop Protection and the ongoing transition in Seeds toward an asset-light model.
- Crop Nutrition was the sole growth segment, rising 15% to $11.6 million, driven by microbeaded fertilizers, while Crop Protection fell 18% to $24.6 million and Seeds and Integrated Products dropped 71% to $3.2 million.
- Gross profit declined 30% to $12.7 million, with gross margin contracting 310 basis points to 32%, impacted by lower revenues, product mix effects, and a non-recurring obsolescence adjustment in inoculants related to inventory normalisation.
- Adjusted EBITDA was $(0.6) million, compared to $9.1 million in Q3 FY2025, with the swing largely attributable to lower gross profit and the absence of prior-year non-cash income associated with the Seeds reorganisation.
- The Pro Farm Group (PFG) business was subject to a foreclosure auction in January 2026 and has been classified as discontinued operations; all financial results discussed reflect continuing operations only.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported fiscal third-quarter 2026 results for the period ended March 31, 2026, reflecting a year of significant transition. The company is navigating softer conditions in Crop Protection, a structural reset in Seeds, and the foreclosure of its Pro Farm Group subsidiary, while continuing to advance cost reduction, liability management, and a strategic review of its continuing operations.
Bioceres Revenue by Segment: Crop Nutrition the Sole Bright Spot
Total revenues fell 23% year-over-year to $39.4 million. Crop Protection, the largest segment, declined 18% to $24.6 million, reflecting softer demand and competitive pricing pressures. Seeds and Integrated Products fell 71% to $3.2 million, continuing to reflect the structural transition toward a more asset-light model following the Seeds reorganisation. Crop Nutrition was the exception, growing 15% to $11.6 million, driven by microbeaded fertilizers.
Gross Profit and Margins Under Pressure
Gross profit declined 30% to $12.7 million, with gross margin contracting from 35% in Q3 FY2025 to 32% in Q3 FY2026. The margin decline reflects lower revenues, an unfavourable product mix shift, and a non-recurring obsolescence adjustment in inoculants associated with inventory normalisation efforts during the period. Bioceres notes this inoculant charge was one-time in nature and not reflective of ongoing operational performance in Crop Nutrition.
Cost Management and Liability Initiatives
SG&A expenses declined 16% year-over-year, reflecting continued organisational streamlining across the company's continuing operations. The company also advanced working capital management initiatives and debt reprofiling efforts during the quarter, including a voluntary bond maturity extension process in Argentina. Net loss for the quarter was $10.0 million, compared to net income of $2.3 million in Q3 FY2025, with the swing driven by lower gross profit and the absence of prior-year non-cash income from contractual and intellectual property arrangement changes tied to the Seeds reorganisation.
“This quarter reflects a period of transition and operational refocusing for the Company. While market conditions in several areas of our business remain challenging, and the effects of the transition in Seeds continue to weigh on reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution across the platform,” said Federico Trucco, Chief Executive Officer of Bioceres.
“We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. While we continue to pursue the appropriate legal course and evaluate constructive alternatives where possible, our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the Company for a more resilient and sustainable future,” Trucco added.
Pro Farm Group and Bioceres Strategic Review
Following the Pro Farm Group foreclosure auction in January 2026 and the related noteholder dispute, Bioceres classified PFG as discontinued operations. All results presented reflect continuing operations only, with prior-year comparatives recast accordingly. In parallel, Bioceres is conducting a strategic review of its continuing operations focused on organisational streamlining, capital allocation optimisation, and ensuring that management attention and resources are directed toward areas of greatest long-term value creation.
